A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications
Yıl: 2013 Cilt: 23 Sayı: 4 Sayfa Aralığı: 390 - 402 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022
A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications
Öz: Bu raporda, Sağlık Bakanlığı, Türkiye İstatistik Kurumu, Türkiye Ruh Sağlığı Profili ve Intercontinental Marketing Service (IMSHealth) verileri kullanılarak ülkemizdeki psikotropik ilaç kullanımı değerlendirilmiştir. İkibinüç yılında 14.24 milyon kutu antidepresan kullanılırken, 2012 yılı sonu itibarıyla bu sayı %162 artışla 37.35 milyon kutu olmuştur. Antipsikotik ilaç kullanımı son 5 yılda %71 artarak 2005 yılında 7.20 milyon kutudan 2012 yılı sonu itibarıyla 12.32 milyon kutuya ulaşmıştır. Antidepresan içeren reçete sayısı son 5 yılda %50 artışla 2007 yılında 18.14 milyondan, 2012 yılı sonunda 26.60 milyona ulaşmıştır. Antipsikotik ilaç içeren reçete sayısı da son 5 yılda %46.7 artışla 2007 yılında 3.92 milyondan, 2012 yılı sonunda 5.76 milyona ulaşmıştır. En kötümser durumda, antidepresan ve antipsikotik ilaç kullanımını gerektiren çoklu psikiyatrik sorunların sırasıyla %20 ve %5 oranında olduğu varsayımında bulunulduğunda bile reçete üzerinden hesaplanan psikiyatrik hastalıkların prevalansı (reçete sayısı/nüfus) oldukça yüksek kalmaktadır. Aile hekimleri- pratisyenler, psikiyatristler, nörologlar ve diğer uzmanlar 2007 yılında antidepresan reçetelemede sırasıyla %33, %37, %20 ve %11’lik paya sahip olmuş; 2012 yılında %48, %31, %14 ve %7’lik paya sahip bulunmuştur. Bu grup hekimlerin 2012 yılında antidepresanların ilk defa reçetelenmesindeki oranlarının ise sırasıyla %37, %34, %19 ve %11 olduğu belirlenmiştir. Aile hekimleri-pratisyenler, psikiyatristler, nörologlar ve diğer uzmanlar 2007 yılında antipsikotik ilaç reçetelemede sırasıyla %18, %67, %13 ve %3’lük paya sahip olurken: 2012 yılında bu değerler sırasıyla %21, %63, %14 ve %2 şeklinde bulunmuştur. Bu grup hekimlerin 2012 yılında antidepresanların ilk defa reçetelenmesindeki oranlarının ise sırasıyla %6, %73, %19 ve %3 olduğu belirlenmiştir. Sonuç olarak, veriler Türkiye’de psikotrop ilaçların gereksiz ve/veya aşırı kullanıldığı izlenimini vermektedir. İlaç kullanımındaki artış, nüfus artışı ve psikiyatrik hastalıklarının insidansının artışıyla ilişkili görünmemektedir. İlk defa reçetelenme rakamları psikiyatrist olmayan hekimlerin psikiyatrik hastalıklara uygun olmayan bir şekilde tanı koyduğunu ve tedavilerini başlattığını düşündürmektedir. Bu durum psikotrop ilaçların reçetelenmesinde yetkilendirme konusunun tekrar ele alınmasını zorunlu kılmaktadır.
Anahtar Kelime: Konular:
Psikofarmakoloji Derneği Türkiye’de psikotrop ilaç tüketimi ve mevcut uygulamaların tıbbi, etik ve ekonomik sonuçları raporu
Öz: This report evaluation of the psychotropic drug usage in Turkey based on the data provided by Intercontinental Marketing Service (IMSHealth), Ministry of Health, Turkish Statistical Institute, Turkish Mental Health Profile. A total of 14.24 millions units of antidepressants were used in 2003. By increasing 162%, annual antidepressant usage reached 37.35 millions units by the end of 2012. Antipsychotic drug usage increased by 71% during the last 5 years, from 7.20 millions units in 2005 to 12.32 millions as of the end of 2012. The total number of prescriptions including an antidepressant was 18.14 millions in 2007, by increasing 50% in the last 5 years, it reached 26.60 millions in 2012. The total number of prescriptions including any antipsychotic drug increased from 3.92 millions in 2007 to 5.76 millions in 2012, increasing by 46.7%. In the worst case scenario considering concurrent psychiatric disorders, prevalence of disorders requiring antidepressants and antipsychotic drugs could be as high as 20% and 5%, respectively. The calculated frequency (prescription/population) was much higher than the worst case scenario estimates. In 2007, family physicans and practitioners, psychiatrists, neurologists, and specialists of other disciplines prescribed 33, 37, 20, and 11% of all antidepressants, respectively. In 2012, they prescribed 48, 31, 14, and 7% of all antidepressants, respectively. The first time antidepressant prescriptions in 2012 were done at the rate of 37, 34, 19, and 11% by above mentioned specialists, respectively. In 2007, family physicans and practitioners, psychiatrists, neurologists, and specialists of other disciplines prescribed 18, 67, 13, and 3% of all antipsychotics, respectively. In 2012, the same set of specialisations prescribed 21, 63, 14, and 2% of antipsychotics, respectively. The “first time” antipsychotics were prescribed at the rate of 6, 73, 19, and 3% by above mentioned order of specialists, respectively. In conclusion, the data suggest that there was an unnecessary and/or excessive prescribing of psychotropic agents. The increase is not related to increased population and/ or prevalance of psychiatric disorders. The numbers of first time prescriptions suggest that non-psychiatrists diagnose and initiate treatment for psychiatric disorders. This requires re-evaluation of authorization to presribe psychotropic agents.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- 1. http://www.medihaber.net/2012/08/12/antidepresan- cilginligina-kim-dur-diyecek/
- 2. http://www.ailehekimligi.com.tr/?Ctrl=HTML&HTMLID=4 548&t=Antidepresanlar_Leblebi_Gibi_Yaziliyor
- 3. Urhan UB. Is there an increase in antidepressant usage in Turkey? An evaluation based on psycho-sociological parameters. Economic Policy Research Foundation of Turkey (TEPAV) Entrepreneurship Institute publications, 2010. (Turkish)
- 4. http://www.haberturk.com/polemik/haber/716797- antidepresanlara-fena-sardik
- 5. Republic of Turkey, Ministry of Health, Refik Saydam Hygiene Center Presidency School of Public Health, Başkent University, National Burden of Disease and Cost Effectiveness Project, Cost Effectiveness Final Report, Ankara, 2004.(Turkish)
- 6. OECD Reviews of Health Systems – Turkey - ISBN 978- 926-405-108-9, A joint OECD-World Bank publication, 2008 (http://www.oecd.org/els/healthsystems/ oecdreviewsofhealthsystems-turkey.htm
- 7. Kilic C. Mental Health Profile of Turkey: Main Report. Ministry of Health. Ankara, 1998.(Turkish)
- 8. Doğan O. Psychiatric Epidemiology, Publications of the Ege University Medical School, Izmir, 2002. (Turkish)
- 9. Health Application Announcement (SUT), Official Gazette, Ankara, 2012. (http://www.resmigazete.gov.tr/ eskiler/2012/06/20120622-24.htmSağlık )
- 10. WHO/Europe, European HFA Database, August 2010.
- 11. Eurostat. New cronos Database-2010.
- 12. h t t p : / / w w w . f d a . g o v / D r u g s / D r u g S a f e t y / InformationbyDrugClass/UCM096273
- 13. h t t p : / / w w w . f d a . g o v / d r u g s / d r u g s a f e t y / postmarketdrugsafetyinformationforpatientsandproviders/ ucm124830.htm
| APA | Aydin N, ÇETİN M, KURT E, SAVAŞ H, AÇIKEL C, KILIC S, BAŞOĞLU C, Turkcapar M (2013). A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications. , 390 - 402. |
| Chicago | Aydin Nazan,ÇETİN Mesut,KURT Erhan,SAVAŞ Haluk,AÇIKEL Cengizhan,KILIC Selim,BAŞOĞLU Cengiz,Turkcapar Mehmet Hakan A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications. (2013): 390 - 402. |
| MLA | Aydin Nazan,ÇETİN Mesut,KURT Erhan,SAVAŞ Haluk,AÇIKEL Cengizhan,KILIC Selim,BAŞOĞLU Cengiz,Turkcapar Mehmet Hakan A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications. , 2013, ss.390 - 402. |
| AMA | Aydin N,ÇETİN M,KURT E,SAVAŞ H,AÇIKEL C,KILIC S,BAŞOĞLU C,Turkcapar M A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications. . 2013; 390 - 402. |
| Vancouver | Aydin N,ÇETİN M,KURT E,SAVAŞ H,AÇIKEL C,KILIC S,BAŞOĞLU C,Turkcapar M A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications. . 2013; 390 - 402. |
| IEEE | Aydin N,ÇETİN M,KURT E,SAVAŞ H,AÇIKEL C,KILIC S,BAŞOĞLU C,Turkcapar M "A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications." , ss.390 - 402, 2013. |
| ISNAD | Aydin, Nazan vd. "A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications". (2013), 390-402. |
| APA | Aydin N, ÇETİN M, KURT E, SAVAŞ H, AÇIKEL C, KILIC S, BAŞOĞLU C, Turkcapar M (2013). A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications. Klinik Psikofarmakoloji Bülteni, 23(4), 390 - 402. |
| Chicago | Aydin Nazan,ÇETİN Mesut,KURT Erhan,SAVAŞ Haluk,AÇIKEL Cengizhan,KILIC Selim,BAŞOĞLU Cengiz,Turkcapar Mehmet Hakan A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications. Klinik Psikofarmakoloji Bülteni 23, no.4 (2013): 390 - 402. |
| MLA | Aydin Nazan,ÇETİN Mesut,KURT Erhan,SAVAŞ Haluk,AÇIKEL Cengizhan,KILIC Selim,BAŞOĞLU Cengiz,Turkcapar Mehmet Hakan A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications. Klinik Psikofarmakoloji Bülteni, vol.23, no.4, 2013, ss.390 - 402. |
| AMA | Aydin N,ÇETİN M,KURT E,SAVAŞ H,AÇIKEL C,KILIC S,BAŞOĞLU C,Turkcapar M A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications. Klinik Psikofarmakoloji Bülteni. 2013; 23(4): 390 - 402. |
| Vancouver | Aydin N,ÇETİN M,KURT E,SAVAŞ H,AÇIKEL C,KILIC S,BAŞOĞLU C,Turkcapar M A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications. Klinik Psikofarmakoloji Bülteni. 2013; 23(4): 390 - 402. |
| IEEE | Aydin N,ÇETİN M,KURT E,SAVAŞ H,AÇIKEL C,KILIC S,BAŞOĞLU C,Turkcapar M "A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications." Klinik Psikofarmakoloji Bülteni, 23, ss.390 - 402, 2013. |
| ISNAD | Aydin, Nazan vd. "A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications". Klinik Psikofarmakoloji Bülteni 23/4 (2013), 390-402. |
